Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience (Q39726002)
scientific article published on March 18, 2010
Language:
(P31) (Q13442814)
(P50) (Q110771654)
(P304) 4651-4656
(P407) (Q1860)
(P433) 23
(P478) 115
(P577) Thursday, March 18, 2010
(P921) (Q861645)
(P953) https://ashpublications.org/blood/article-pdf/115/23/4651/1327083/zh802310004651.pdf
http://www.bloodjournal.org/cgi/content/abstract/115/23/4651
http://ashpublications.org/blood/article-pdf/115/23/4651/1327083/zh802310004651.pdf
(P1433) (Q885070)
(P1476) "Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience" (language: en)
(P2093) Ari Zimran
Mici Philips
Drorit Attias
Marina Jmoudiak
Maher Deeb
Nan Wang
Kiran Bhirangi
Deborah Elstein
Gabriel M. Cohn
other details
description scientific article published on March 18, 2010

External Links